SUBSCRIBE Blog with us: BLOGbiotech

Breaking News

• Email
• Print
• Share
• More News

Dec 7 2006, 9:03 AM EST

Rheologics Establishes Scientific Advisory Board

MARKETWIRE

Dec 07, 2006 EXTON, PA MARKET WIRE

Rheologics, Inc., a subsidiary of Rheologics Technologies, Inc. (PINKSHEETS: RTGI) ("Rheologics"), the leader in the study of blood viscosity and its relationship to cardiovascular disease, is pleased to announce that the Company has established its Scientific Advisory Board with the appointment of nine members, including the following cardiologists, hematologists, as well as pharmaceutical and bioengineering specialists:

Rodger L. Bick, MD, PhD, FACP

Since 1992, Dr. Bick has served as Clinical Professor of Medicine at the University of Texas Southwestern Medical Center. He is also Director of the Dallas Thrombosis Hemostasis & Vascular Medicine Clinical Center. Previously, he was Professor of Medicine at the UCLA Center for the Health Sciences, where he held a fellowship in Hematology and Medical Oncology. Prior to that, he completed an additional Coagulation Hematology Fellowship at the UC Irvine School of Medicine in affiliation with the Research Division of Hyland Laboratories. He was the founder and principal of ThromboCare Laboratories, a nationally recognized clinical testing facility for thrombosis-related disorders which was recently sold to a laboratory service company. Dr. Bick has published numerous journal articles and is the editor of the peer-review scientific journal Clinical and Applied Thrombosis/Hemostasis.

Anthony T. Cheung, PhD

Dr. Cheung is Professor Emeritus on Active Recall and Vice Chair for Research at the University of California-Davis School of Medicine. Since 1982, he has served on the faculty of the University of California-Davis School of Medicine as Professor of Clinical Pathology, Director of Biomedical Engineering Division and Chair of Advisory Research Committee of the Department of Medical Pathology and Laboratory Medicine. Dr. Cheung came to UC-Davis after serving at the California Institute of Technology for five years as a Research Scientist and Senior Fellow. Dr. Cheung is an Advisory Committee Member for an NIH consortium research grant -- "New Paradigms in the Design of Blood Substitutes" -- currently in place at Albert Einstein College of Medicine (Bronx, NY), University of California at San Diego (La Jolla, CA), and Carnegie Mellon University (Pittsburgh, PA). In addition, he serves as a reviewer of several scientific journals, has authored or co-authored over 100 scientific and clinical research papers, and has presented in over 100 national and international conferences.

Young I. Cho, PhD

Dr. Cho is Professor of Mechanical Engineering & Mechanics at Drexel University, where he has served as a member of the faculty since 1985. Dr. Cho initiated his research in blood viscometry as a member of the technical staff at NASA's Jet Propulsion Laboratory at the California Institute of Technology, where he was responsible for a range of experiments to determine the effect of space travel on the blood viscosity of astronauts. In 1986, Dr. Cho held a joint faculty appointment at the Argonne National Laboratory under the U.S. Department of Energy to develop a degradation-free non-Newtonian fluid. In 1993, he was nominated by the U.S. DoE and elected as the chairman of the Advanced Fluid Committee under the International Energy Agency. Dr. Cho has authored/co-authored approximately 150 papers in the area of heat transfer, fluid mechanics, rheology, aerodynamics, acoustics, combustion and energy and is a reviewer for a number of peer-review journals.

Gary C. Cupit, PharmD

Dr. Cupit is President of Enzo Therapeutics, Inc., a division of Enzo Biochem, Inc. Previously, he was President and CEO of Sapphire Therapeutics, a private biopharmaceutical company. Prior to Sapphire, Gary was Vice President, Global Business Devel

• Email
• Print
• Share
• More News

CAREER CENTER

WEBINARS

PODCASTS

MOST POPULAR